IO Biotech, Inc. Common Stock
Symbol: IOBT (NASDAQ)
Company Description:
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
- Today's Open: $0.7921
- Today's High: $1.019
- Today's Low: $0.752
- Today's Volume: 8.23M
- Yesterday Close: $0.8202
- Yesterday High: $0.9065
- Yesterday Low: $0.6888
- Yesterday Volume: 71.03M
- Last Min Volume: 27
- Last Min High: $0.96
- Last Min Low: $0.96
- Last Min VWAP: $0.96
- Name: IO Biotech, Inc. Common Stock
- Website: https://www.iobiotech.com
- Listed Date: 2021-11-05
- Location: COPENHAGEN, G7
- Market Status: Active
- CIK Number: 0001865494
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $54.04M
- Round Lot: 100
- Outstanding Shares: 65.88M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-29 | 8-K | View |
2025-08-19 | SCHEDULE 13D/A | View |
2025-08-14 | 10-Q | View |
2025-08-14 | 8-K | View |
2025-08-11 | 8-K | View |
2025-07-31 | EFFECT | View |
2025-07-29 | CORRESP | View |
2025-07-29 | UPLOAD | View |
2025-07-24 | S-3 | View |
2025-06-27 | 8-K | View |
2025-06-20 | 8-K | View |
2025-06-11 | EFFECT | View |
2025-06-09 | CORRESP | View |
2025-06-09 | 8-K | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |